CD8A and neoplasm: For example, tumors from patients with advanced disease were found to have deficiencies in their MHC I processing pathway, being unable to present tumor peptides in the context of MHC class I alleles to CD8+ CTLs [50,51], while other tumors have down regulated the expression of peptide sequences that could serve as antigens for T cells [52].